| Primary |
| Gaucher's Disease |
46.7% |
| Product Used For Unknown Indication |
32.8% |
| Premedication |
2.7% |
| Antiphospholipid Syndrome |
2.3% |
| Osteoporosis |
2.3% |
| Hypertension |
1.5% |
| Prophylaxis Against Transplant Rejection |
1.5% |
| Anaemia |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Lipidosis |
1.2% |
| Pain |
1.2% |
| Hepatitis C |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Insomnia |
0.8% |
| Supplementation Therapy |
0.8% |
| Tooth Infection |
0.8% |
| Antibiotic Therapy |
0.4% |
| Asthma |
0.4% |
| Blood Cholesterol Increased |
0.4% |
| Cerebrovascular Accident |
0.4% |
|
| Infusion Related Reaction |
15.3% |
| Bone Pain |
8.5% |
| Death |
6.8% |
| Maternal Exposure During Pregnancy |
6.8% |
| Adverse Event |
5.1% |
| Completed Suicide |
5.1% |
| Hepatomegaly |
5.1% |
| Myocardial Infarction |
5.1% |
| Neoplasm Malignant |
5.1% |
| Abdominal Pain |
3.4% |
| Anxiety |
3.4% |
| Blood Immunoglobulin G Increased |
3.4% |
| Condition Aggravated |
3.4% |
| Deep Vein Thrombosis |
3.4% |
| Depression |
3.4% |
| Gallbladder Disorder |
3.4% |
| Heart Rate Decreased |
3.4% |
| Hepatic Cancer |
3.4% |
| Hepatic Neoplasm Malignant |
3.4% |
| Neuropathy Peripheral |
3.4% |
|
| Secondary |
| Gaucher's Disease |
67.9% |
| Product Used For Unknown Indication |
21.4% |
| Diabetes Mellitus |
3.6% |
| Gastrooesophageal Reflux Disease |
3.6% |
| Lipidosis |
3.6% |
|
| Bone Pain |
15.4% |
| Type 1 Diabetes Mellitus |
15.4% |
| Breast Cancer In Situ |
7.7% |
| Completed Suicide |
7.7% |
| Gastrointestinal Disorder |
7.7% |
| Lyme Disease |
7.7% |
| Lymphoma |
7.7% |
| Multiple Myeloma |
7.7% |
| Pain In Extremity |
7.7% |
| Rash |
7.7% |
| White Blood Cell Count Increased |
7.7% |
|
| Concomitant |
| Gaucher's Disease |
57.1% |
| Contraception |
14.3% |
| Premedication |
14.3% |
| Product Used For Unknown Indication |
14.3% |
|
| Throat Tightness |
40.0% |
| Death |
20.0% |
| Terminal State |
20.0% |
| Weight Decreased |
20.0% |
|
